Európai Unió -
dán -
EMA (European Medicines Agency)
levodopa/carbidopa/entacapone orion
orion corporation - levodopa, carbidopa, entakapon - parkinsons sygdom - nervesystem - levodopa/carbidopa/entacapone orion er indiceret til behandling af voksne patienter med parkinsons sygdom og slutningen af dosis motor udsving ikke stabiliseret på levodopa / dopa-decarboxylase (ddc)-inhibitor behandling.
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
orionox depot 10 mg depottabletter
orion corporation - oxycodonhydrochlorid - depottabletter - 10 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
orionox depot 20 mg depottabletter
orion corporation - oxycodonhydrochlorid - depottabletter - 20 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
orionox depot 40 mg depottabletter
orion corporation - oxycodonhydrochlorid - depottabletter - 40 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
orionox depot 80 mg depottabletter
orion corporation - oxycodonhydrochlorid - depottabletter - 80 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
orionox depot 5 mg depottabletter
orion corporation - oxycodonhydrochlorid - depottabletter - 5 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
ropinirol "orion" 4 mg depottabletter
orion corporation - ropinirolhydrochlorid - depottabletter - 4 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
ropinirol "orion" 8 mg depottabletter
orion corporation - ropinirolhydrochlorid - depottabletter - 8 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
alfuzosin "orion" 10 mg depottabletter
orion corporation - alfuzosinhydrochlorid - depottabletter - 10 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
alfuzosin "orion" 2,5 mg filmovertrukne tabletter
orion corporation - alfuzosinhydrochlorid - filmovertrukne tabletter - 2,5 mg